U.S. Oil and Gas Stock News

Consumer sentiment shock hits Monarch Casino & Resort (MCRI) The sharp drop in the latest University of Michigan consumer sentiment survey sent several consumer discretionary names lower, and Monarch Casino & Resort (MCRI) fell 2.6% in the afternoon session. See our latest analysis for Monarch Casino & Resort. Beyond today’s consumer sentiment shock, Monarch’s recent weakness, including a 3.33% one day share price decline and softer short term returns, contrasts with its much stronger 1 year...

Event driven snapshot of Sarepta Therapeutics Sarepta Therapeutics (SRPT) is back on investor radar after recent share price swings, including a 13% gain over the past week and a 19% move over the past month, against a weaker one year return. See our latest analysis for Sarepta Therapeutics. The recent 19.2% 30 day share price return contrasts with a weaker 1 year total shareholder return of a 68.7% decline, suggesting that short term momentum has improved while longer term holders remain...

Credit Acceptance Corporation recently appointed former Deutsche Telekom and T-Mobile executive Steffen Schumann as its Chief Business Officer, reporting to CEO Vinayak Hegde, with responsibilities spanning enterprise business planning, pricing strategy, advanced analytics, and dealer scorecarding. The hire underscores Credit Acceptance’s effort to tighten execution and translate analytics-driven insights into actions, at a time when management is seeing early signs of operational stability...

If you are wondering whether DoorDash is priced attractively or already reflects too much optimism, this article breaks down what the current share price may be implying about the company. DoorDash shares recently closed at US$146.60, after a 7 day return of an 8.4% decline, a 30 day return of a 16.9% decline, and a year to date return of a 33.3% decline. The 1 year return sits at a 19.8% decline and the 3 year return at 129.3%. These shifts in returns have put more attention on how the...

Why recent operating pressure at Rogers (ROG) matters for shareholders Recent reports of 5.5% annual sales declines for two straight years and a 7.2 percentage point drop in operating margin put Rogers (ROG) in focus for investors watching earnings power and share price resilience. See our latest analysis for Rogers. Despite the operating pressure, Rogers has seen momentum build recently, with a 16.9% 90 day share price return and a 61.9% 1 year total shareholder return, although longer term...

Murphy Oil recently increased its quarterly dividend by 8% to US$0.35 per share, continued repurchasing stock under its remaining US$550.00 million authorization, and highlighted cost efficiencies including a 20% year-over-year reduction in lease operating expenses and lower Eagle Ford drilling costs. The company’s Vietnamese assets have shifted from a speculative position to a clearer growth platform, with Lac Da Vang first oil targeted for late 2026 and additional Hai Su Vang appraisal...

Why JinkoSolar Holding (NYSE:JKS) is on investor radars today JinkoSolar Holding (NYSE:JKS) has drawn investor attention after recent share price moves, with the stock closing at US$25.29 and showing mixed returns over the past year and over the past 3 months. See our latest analysis for JinkoSolar Holding. For JinkoSolar, short term share price momentum has been positive, with a 7 day share price return of 5.77%. The year to date share price return is a 9.48% decline, and the 1 year total...

Earlier in March 2026, Okta announced Okta for AI Agents, a new platform launching on April 30, 2026 to help enterprises discover, register, and govern both sanctioned and shadow AI agents as first-class identities across their environments. This move extends Okta’s identity platform into managing non-human AI agents, potentially making it a core infrastructure layer for organizations scaling AI-powered operations and security controls. We’ll now examine how Okta for AI Agents could...

Some investors may be wondering if Eli Lilly is still worth its current price, or if the recent run has already baked in too much optimism. The stock closed at US$878.24, with returns of a 3.5% decline over 7 days, a 16.5% decline over 30 days, an 18.7% decline year to date, a 7.1% gain over 1 year, a 156.0% gain over 3 years and a very large gain over 5 years. Recent headlines have focused on Eli Lilly's role in high profile drug categories, including weight management and other blockbuster...

Structure Therapeutics recently reported positive topline Phase 2 ACCESS II and related study data for aleniglipron, an oral once-daily GLP-1 receptor agonist for people living with obesity or overweight, showing clinically meaningful and statistically significant weight loss alongside a tolerability profile consistent with its drug class. A particularly interesting aspect is that aleniglipron’s weight loss efficacy was described as comparable to injectable GLP-1 therapies while using an...

With no single headline event driving attention, RLJ Lodging Trust (RLJ) is drawing interest as investors weigh its recent share performance in relation to its hotel focused REIT model and current earnings profile. See our latest analysis for RLJ Lodging Trust. Recent trading has been softer, with a 1 month share price return showing a decline of 6.73% and a year to date share price return showing a decline of 2.22%. The 1 year total shareholder return of 0.71% hints at only modest overall...

Tetra Tech (NasdaqGS:TTEK) has appointed Eric W. Thornburg, a water industry veteran with over 40 years of sector experience, to its Board of Directors. Thornburg most recently served as CEO of H2O America, adding executive leadership experience directly tied to water infrastructure and services. The board appointment reflects a focus on water and utilities oriented governance at a time when water infrastructure and environmental solutions remain central to Tetra Tech's business. Tetra Tech...

On March 19, 2026, Box increased its share repurchase authorization by US$500 million to a total of US$1.86 billion and extended the program through September 30, 2027. Alongside this larger buyback, co-founder Aaron Levie outlined an AI-focused plan that channels automation savings into human-led customer success, underscoring how Box aims to blend technology gains with service expansion. We’ll now examine how Box’s expanded US$1.86 billion buyback program influences its investment...

Booz Allen Hamilton recently announced it was selected by the National Weather Service to build a first-of-its-kind cloud-based data platform, while also advancing its AI-native Vellox cyber defense suite and investing in AI-RAN firm ODC for future 5G and 6G applications. Together, these moves highlight Booz Allen’s growing role in mission-critical federal cloud, cybersecurity, and AI-infused network infrastructure that underpins US national resilience. We’ll now examine how Booz Allen’s new...

In March 2026, Hormel Foods announced it had fully integrated AI-powered demand and supply planning across more than 70 global sites via the o9 Digital Brain platform in collaboration with Accenture, while also affirming a quarterly dividend of US$0.2925 per share and being removed from the FTSE All-World Index (USD). This combination of advanced digital supply chain capabilities and ongoing brand innovation, particularly in premium and globally inspired pizza toppings, underscores Hormel’s...

Crown Holdings (CCK) shares are in focus after the company expanded Dr. John M. Rost’s responsibilities to Executive Vice President and Chief Operating Officer, Asia Pacific and Transit Packaging, a move centered on two key revenue segments. See our latest analysis for Crown Holdings. The executive reshuffle comes after a 1-month share price return decline of 13.11% and a year-to-date share price return decline of 4.42%, while the 1-year total shareholder return stands at 12.81%. This...

In March 2026, Xenon Pharmaceuticals’ chief medical officer Christopher John Kenney reported a routine, tax-related sale of 1,410 vested restricted stock unit shares, worth about US$78,000, executed under a sell-to-cover instruction. This insider transaction followed Xenon’s positive topline Phase 3 results for lead candidate azetukalner and the completion of an upsized offering of nearly US$750 million, underscoring the company’s progress in both clinical development and capital...

Why Seaboard (SEB) is on investors’ radar today Seaboard (SEB) has drawn attention after recent share price moves, including a 2.18% 1 day return and double digit gains over the past week, month and past 3 months. Those swings are prompting investors to look more closely at how Seaboard’s diversified operations in pork, commodity trading, marine shipping, fuels, power and turkey production, together with its current valuation metrics, fit into their broader portfolio decisions. See our latest...

Index inclusion puts Lamb Weston Holdings (LW) on more investor radars Lamb Weston Holdings (LW) was added to the Russell Small Cap Value Index on 20 March 2026, a shift that can draw new attention as index funds and passive vehicles adjust their holdings. This kind of index inclusion often prompts mechanical buying from funds that track the benchmark, which can change trading volumes and ownership patterns even if the company’s operations and fundamentals remain unchanged. See our latest...

Why Nasdaq’s tokenized collateral move with Talos matters Nasdaq (NDAQ) is drawing fresh attention after announcing a partnership with Talos to integrate tokenized collateral workflows into its Calypso and Trade Surveillance platforms. This step directly targets institutional use of digital assets. See our latest analysis for Nasdaq. Despite headlines around tokenized collateral and Nasdaq’s presence at the Digital Asset Summit, the stock’s recent momentum has softened, with a 17.6% 90-day...

NewAmsterdam Pharma announced it would present multiple Phase 3 and outcomes-related data sets for its oral CETP inhibitor obicetrapib at the ACC.26 cardiology meeting in New Orleans, highlighting kidney function, safety and lipid-related cardiovascular risk metrics in high‑risk patients. An interesting angle for investors is that obicetrapib is being positioned as a low‑dose, oral option intended to complement or expand existing LDL‑lowering approaches, with European commercialization...

Assessing OneMain Holdings after recent share price pressure OneMain Holdings (OMF) has come under pressure recently, with the stock showing declines over the past week, month and past 3 months. This has prompted investors to reassess its valuation and recent financial profile. See our latest analysis for OneMain Holdings. The current share price of US$51.55 reflects recent weakness, with a 1 month share price return of a 6.31% decline and a year to date share price return of a 25.37%...

CrowdStrike recently unveiled a wave of AI- and agent-focused upgrades to its Falcon platform, expanded collaborations with IBM and Intel, and new offerings like Agentic MDR, Falcon Data Security, and Charlotte AI AgentWorks, while deepening ecosystem ties with partners including AWS, NVIDIA, EY, Nebius, and WWT. These moves position CrowdStrike at the center of “agentic SOC” and AI security workflows just as investors are increasingly worried that powerful new frontier AI models such as...

In March 2026, Dell Technologies (NYSE:DELL) introduced a reimagined commercial device portfolio aimed at enterprise users. The new Dell Pro notebooks and desktops feature AI ready hardware, Copilot+ experiences, modular design, and updated Intel and AMD chips. The launch shifts attention from Dell's earlier focus on AI servers and quantum security to client devices used by everyday workers and IT teams. Dell Technologies enters this product cycle with recent share price momentum, with...